BTC, DOGE, XRP and other cryptocurrency enthusiasts lock in stable daily income through SWL Miner

London, UK, July 10, 2025 (GLOBE NEWSWIRE) — SWL Miner is a free cloud mining platform founded in 2017 and headquartered in Yorkshire, England, providing mining services for multiple currencies such as Bitcoin, Dogecoin, Litecoin, etc. The company is pleased to announce the launch of a new mobile application. The timely release of this application […]

BTC, DOGE, XRP and other cryptocurrency enthusiasts lock in stable daily income through SWL Miner

BTC, DOGE, XRP and other cryptocurrency enthusiasts lock in stable daily income through SWL Miner SWL Miner is a free cloud mining platform founded in 2017 and headquartered in Yorkshire, England, providing mining services for multiple currencies such as Bitcoin, Dogecoin, Litecoin, etc. The company is pleased to announce the launch of a new mobile

Sutter’s CPMC Debuts Sound Wave Therapy to Fight Hard-to-Treat Liver Tumors

San Francisco, July 10, 2025 (GLOBE NEWSWIRE) — Physicians at Sutter's CPMC in San Francisco are using a leading-edge medical technology to care for people with liver tumors. FDA-approved histotripsy uses quick, highly focused sound waves to break apart unwanted tissue, such as tumors, without any incisions. These tiny, precise “pulses” of energy, generated by

Sutter’s CPMC Debuts Sound Wave Therapy to Fight Hard-to-Treat Liver Tumors

Sutter's CPMC Debuts Sound Wave Therapy to Fight Hard-to-Treat Liver Tumors With Histotripsy, Sutter Enhances Its Advanced Organ Therapies Program And Sets A New Standard For Delivering Personalized Liver Care GlobeNewswire July 10, 2025 San Francisco, July 10, 2025 (GLOBE NEWSWIRE) — Physicians at Sutter's CPMC in San Francisco are using a leading-edge medical technology

Medline launches new ComfortTemp® Patient Warming System with blankets and gowns

System built to provide effective body-temperature control; features lock-in hose connection and flexible design Medlinetoday officially announced the launch of the ComfortTemp® Patient Warming System, including disposable blankets and gowns, a product designed to improve upon similar systems on the market and provide unparalleled comfort and temperature regulation for patients. The 510K Class 2 device

Loopback Analytics Named to Dallas Business Journal’s Fast 50 List for Second Consecutive Year

Loopback Analytics, a healthcare data and services company accelerating access and outcomes in specialty care, has been named to the Dallas Business Journal's Fast 50 list for the second year in a row. The annual list honors the fastest-growing private companies in North Texas based on revenue growth over the past three years. https://mma.prnewswire.com/media/2515924/Loopback_Analytics_Logo.jpg Loopback's

FHLBank San Francisco Awards $5.1 Million in Grants for Affordable Housing in Nevada

SAN FRANCISCO, July 10, 2025 (GLOBE NEWSWIRE) — The Federal Home Loan Bank of San Francisco (FHLBank San Francisco) today announced $5.1 million in affordable housing grants awarded to Nevada-based affordable housing developers through its Affordable Housing Program (AHP) Nevada Targeted Fund. The grants are being awarded to five projects in Nevada that will collectively

FHLBank San Francisco Awards $5.1 Million in Grants for Affordable Housing in Nevada

FHLBank San Francisco Awards $5.1 Million in Grants for Affordable Housing in Nevada Grants from the Nevada Targeted Fund will add over 270 units of affordable housing in the Silver State GlobeNewswire July 10, 2025 SAN FRANCISCO, July 10, 2025 (GLOBE NEWSWIRE) — The Federal Home Loan Bank of San Francisco (FHLBank San Francisco) today

Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS)

— Important milestone towards public reimbursement for a new treatment option for eligible Canadian patients living with moderate to severe hidradenitis suppurativa (HS) — Following this important milestone, Cosentyx has been listed in Québec Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce the successful conclusion of negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) on

Slipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology

BLUE BELL, Pa., July 10, 2025 (GLOBE NEWSWIRE) — Slipstream, a trusted technology partner serving the Pharmaceutical and Biopharmaceutical industry, is proud to announce its co-authorship of a groundbreaking study on Hereditary Hemorrhagic Telangiectasia (HHT), recently published in the American Journal of Hematology. The study, “Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia”,

Scroll to Top